RxweightHub by Dr Watson

Do you have anything to say.

Check out our weight loss meds available

Myobloc one of the best

Cold chain shipping, specialized storage, pharmacy infrastructure for biologics - that was the barrier to GLP-1 access. Eli Lilly's Foundayo removes all of it.
It's a small molecule pill that ships without refrigeration No needles, No cold chain Just a daily pill that can be manufactured and distributed globally.

Novo Nordisk's competing oral GLP-1 launched a few months ahead, and the early data tells a clear story:600,000 prescriptions in March. These aren't people switching from injectables. They're entirely new patients - people who would not do a weekly injection but will take a daily pill. Remove the access barrier, and an entirely new population shows up.

Foundayo pills available now send a DM to get started

Foundayo (orforglipron) is a newly approved, once-daily oral GLP-1 receptor agonist medication developed by Eli Lilly for chronic weight management. Approved by the FDA in April 2026, it is designed for adults with obesity or those who are overweight with weight-related medical conditions, intended for use with a reduced-calorie diet and increased physical activity. Dm now to get started.